Publication Registration: |
Wednesday, December 5, 2007 |
Goods and Services Information
|
Description:
|
(1) - Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the peripheral nervous system, namely, poly neuropathy, facial paralysis, entrapment neuropathy; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss; pharmaceutical preparations, namely, allergy medication; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations, namely, hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; pharmaceutical preparations for the treatment of kidney diseases; antibiotics; pharmaceuticals, namely, vaccines for the treatment of infectious diseases; diagnostic preparations for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of sleep disorder, namely insomnia; pharmaceuticals for human use, namely, anthelmintics; pharmaceuticals for human use, namely, germicides.
(2) - Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of the peripheral nervous system, namely, poly neuropathy, facial paralysis, entrapment neuropathy; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss; pharmaceutical preparations, namely, allergy medication; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations, namely, hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; pharmaceutical preparations for the treatment of kidney diseases; antibiotics; pharmaceuticals, namely, vaccines for the treatment of infectious diseases; diagnostic preparations for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of sleep disorder, namely insomnia; pharmaceuticals for human use, namely, anthelmintics; pharmaceuticals for human use, namely, germicides.
|